China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial Results
05 Novembre 2012 - 2:00PM
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or
the "Company"), a leading China-based biopharmaceutical company
focused on the research, development, manufacture, marketing and
sales of hospital-based medical products, today announced that the
Company plans to release third quarter 2012 financial results on
Sunday, November 25, 2012 .
The Company will hold a conference call at 8:00 a.m. ET on
Monday, November 26 to discuss third quarter 2012 results.
Listeners may access the call by dialing:
United States toll free: |
1-855-500-8701 |
China toll free: |
400-1200654 |
Hong Kong toll free: |
800-903737 |
United Kingdom toll free: |
0800-0159724 |
International: |
65-6723-9385 |
Conference ID: |
64309501 |
A live webcast and replay of the earnings call will be available
through the Company's website www.nkbp.com.
About China Nuokang Bio-Pharmaceutical
Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading
biopharmaceutical company in China focused on the research,
development, manufacture, marketing and sales of hospital-based
medical products. The Company provides a diversified portfolio of
products across more than 4,200 hospitals in China. Nuokang's
principal products include Baquting®, China's leading hemocoagulase
product by market share; Kaitong®, a lipid emulsion alprostadil
product for the treatment of peripheral vascular diseases,
cardiocerebral microcirculation disorders and post-surgery
thrombosis; and alpha lipoic acid capsules, or ALA, an antioxidant
product that addresses diabetic neuropathy. The Company's product
pipeline includes product candidates under development in
hematological, cardiovascular and cerebrovascular disease
diagnosis, treatment and prevention. Please visit www.nkbp.com for
more information.
CONTACT: China Nuokang Bio-Pharmaceutical Inc.
Mr. Steven Duan
Vice President of Investor Relations
Email: dsz@nkbp.com
ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516 or (646) 405-5180
Email: robert.koepp@icrinc.com
Grafico Azioni China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ): 0 articoli recenti
Più China Nuokang Bio-Pharmaceutical Inc. Articoli Notizie